Clinical trial

Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients

NCT00798070

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention dtEC→dtT Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention FEC→T Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients

Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2007-02-01

PhasePHASE3

Conditions

Breast Cancerverified · MONDO: breast cancer

Interventions

dtEC→dtTDRUG

FEC→TDRUG

Sponsors & collaborators

Karolinska University Hospitallead sponsor

Swedish Breast Cancer Groupcollaborator

Austrian Breast & Colorectal Cancer Study Groupcollaborator

GBG Forschungs GmbHcollaborator

Mapped research locations

DresdenGermany3 HanoverGermany2 MainzGermany2 BonnGermany2 LinzAustria2 BerlinGermany1 ViennaAustria1 StockholmSweden1 HeidelbergGermany1 CologneGermany1 GothenburgSweden1 MünsterGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00798070 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.